Company / Working Capital
Neurogene Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$255.4M
FY2025
5-year range
$72.5M / $300.8M
FY2021-FY2025
Trend
-15.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $139M to $255M over the past 6 years.
Based on SEC 10-K filings.
$255M in FY2025.
Improved from $139M to $255M over the past 6 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital decreased 15.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $255.4M | -15.1% |
| FY2024 | $300.8M | +116.6% |
| FY2019 | $138.9M | +91.4% |
| FY2018 | $72.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026